Specific interactions between the Candida albicans ABC transporter Cdr1p ectodomain and a d‐octapeptide derivative inhibitor

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Molecular Microbiology

• Publication date

  2012-08-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1111/j.1365-2958.2012.08140.xPMID 22788839PMCID PMC3418399
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A D-octapeptide drug efflux pump inhibitor acts synergistically with azoles in a murine oral candidiasis infection model.

  2012cited by this paper
• Toward understanding the mechanism of action of the yeast multidrug resistance transporter Pdr5p: a molecular modeling study.

  2011influential reference
• The multidrug transporter Pdr5: a molecular diode?

  2011cited by this paper
• Chimeras of Candida albicans Cdr1p and Cdr2p reveal features of pleiotropic drug resistance transporter structure and function

  2011cited by this paper
• Fungal PDR transporters: Phylogeny, topology, motifs and function.

  2010cited by this paper
• Multidrug efflux pumps: Substrate selection in ATP‐binding cassette multidrug efflux pumps – first come, first served?

  2010cited by this paper
• Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding

  2009cited by this paper
• The amino acid residues of transmembrane helix 5 of multidrug resistance protein CaCdr1p of Candida albicans are involved in substrate specificity and drug transport.

  2009cited by this paper
• Relative Contributions of the Candida albicans ABC Transporters Cdr1p and Cdr2p to Clinical Azole Resistance

  2009cited by this paper
• Efflux-Mediated Antifungal Drug Resistance

  2009cited by this paper
• ABC Transporter Cdr1p Contributes More than Cdr2p Does to Fluconazole Efflux in Fluconazole-Resistant Candida albicans Clinical Isolates

  2008cited by this paper
• The yeast Pdr5p multidrug transporter: how does it recognize so many substrates?

  2007influential reference
• Inhibition of fungal ABC transporters by unnarmicin A and unnarmicin C, novel cyclic peptides from marine bacterium.

  2007cited by this paper
• Membrane fluidity and lipid composition in clinical isolates of Candida albicans isolated from AIDS/HIV patients.

  2007cited by this paper
• Characterization of Three Classes of Membrane Proteins Involved in Fungal Azole Resistance by Functional Hyperexpression in Saccharomyces cerevisiae

  2007cited by this paper
• Uptake or extrusion: crystal structures of full ABC transporters suggest a common mechanism

  2007cited by this paper
• Structure of the multidrug ABC transporter Sav1866 from Staphylococcus aureus in complex with AMP‐PNP

  2007cited by this paper
• Structure of a bacterial multidrug ABC transporter

  2006influential reference
• Characterization of Cdr1p, a major multidrug efflux protein of Candida albicans: purified protein is amenable to intrinsic fluorescence analysis.

  2006cited by this paper
• Heterozygosity and functional allelic variation in the Candida albicans efflux pump genes CDR1 and CDR2

  2006cited by this paper
• Comparative Protein Structure Modeling Using Modeller

  2006cited by this paper
• Yeast ATP-binding cassette transporters: cellular cleaning pumps.

  2005cited by this paper
• Quinazolinone Fungal Efflux Pump Inhibitors. Part 2. In vitro Structure—Activity Relationships of (N‐Methyl‐piperazinyl)‐Containing Derivatives.

  2005cited by this paper
• Phosphorylation of Candida glabrata ATP-binding Cassette Transporter Cdr1p Regulates Drug Efflux Activity and ATPase Stability*

  2005cited by this paper
• The role of hydrogen bond acceptor groups in the interaction of substrates with Pdr5p, a major yeast drug transporter.

  2005cited by this paper
• Surface-Active Fungicidal d-Peptide Inhibitors of the Plasma Membrane Proton Pump That Block Azole Resistance

  2005cited by this paper
• Quinazolinone fungal efflux pump inhibitors. Part 2: In vitro structure-activity relationships of (N-methyl-piperazinyl)-containing derivatives.

  2004cited by this paper
• Chemosensitization of Fluconazole Resistance in Saccharomyces cerevisiae and Pathogenic Fungi by a d-Octapeptide Derivative

  2004cited by this paper
• Quinazolinone-based fungal efflux pump inhibitors. Part 1: Discovery of an (N-methylpiperazine)-containing derivative with activity in clinically relevant Candida spp.

  2004cited by this paper
• Studies with Novel Pdr5p Substrates Demonstrate a Strong Size Dependence for Xenobiotic Efflux*

  2003cited by this paper
• Reversal of antifungal resistance mediated by ABC efflux pumps from Candida albicans functionally expressed in yeast.

  2003cited by this paper
• Candida glabrata ATP-binding Cassette Transporters Cdr1p and Pdh1p Expressed in aSaccharomyces cerevisiae Strain Deficient in Membrane Transporters Show Phosphorylation-dependent Pumping Properties*

  2002cited by this paper
• The E. coli BtuCD Structure: A Framework for ABC Transporter Architecture and Mechanism

  2002cited by this paper
• A Novel Screening for Inhibitors of a Pleiotropic Drug Resistant Pump, Pdr5, in Saccharomyces cerevisiae

  2001influential reference
• Mechanisms of fluconazole resistance in Candida albicans isolates from Japanese AIDS patients.

  2001cited by this paper
• Functional Expression of Candida albicans Drug Efflux Pump Cdr1p in a Saccharomyces cerevisiae Strain Deficient in Membrane Transporters

  2001cited by this paper
• Microbial fermentation-derived inhibitors of efflux-pump-mediated drug resistance.

  2001cited by this paper
• The transmembrane domain 10 of the yeast Pdr5p ABC antifungal efflux pump determines both substrate specificity and inhibitor susceptibility

  2000cited by this paper
• Genetic separation of FK506 susceptibility and drug transport in the yeast Pdr5 ATP-binding cassette multidrug resistance transporter.

  1998cited by this paper
• ATPase and Multidrug Transport Activities of the Overexpressed Yeast ABC Protein Yor1p*

  1998cited by this paper
• Synthetic histatin analogues with broad-spectrum antimicrobial activity.

  1997cited by this paper
• Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene.

  1997cited by this paper
• Anticancer Drugs, Ionophoric Peptides, and Steroids as Substrates of the Yeast Multidrug Transporter Pdr5p*

  1996cited by this paper
• Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors

  1996cited by this paper
• Multiple efflux mechanisms are involved in Candida albicans fluconazole resistance

  1996cited by this paper
• Molecular cloning and characterization of a novel gene of Candida albicans, CDR1, conferring multiple resistance to drugs and antifungals

  1995cited by this paper
• Yeast multidrug resistance: The PDR network

  1995cited by this paper
• Genetics and biochemistry of yeast multidrug resistance.

  1994cited by this paper
• Isogenic strain construction and gene mapping in Candida albicans.

  1993cited by this paper
• A Method for Gene Disruption That Allows Repeated Use of URA3 Selection in the Construction of Multiply Disrupted Yeast Strains

  1987cited by this paper

• Multidrug efflux pumps and innate azole resistance of Mucor lusitanicus

  2025cites this paper
• Use of gain-of-function suppressor screening to elucidate Candida albicans Cdr1 efflux mechanism, inhibition, and drug resistance

  2025cites this paper
• Mathematical Modeling and Hyers-Ulam Stability for a Nonlinear Epidemiological Model with $\Phi_p$ Operator and Mittag-Leffler Kernel

  2024cites this paper
• Modulators of Candida albicans Membrane Drug Transporters: A Lucrative Portfolio for the Development of Effective Antifungals

  2024cites this paper
• Cryo-EM structures of Candida albicans Cdr1 reveal azole-substrate recognition and inhibitor blocking mechanisms

  2024cites this paper
• Update on the structure and function of Candida albicans drug efflux protein, Cdr1.

  2024cites this paper
• Azole Combinations and Multi-Targeting Drugs That Synergistically Inhibit Candidozyma auris

  2024cites this paper
• Microbial resistance: The role of efflux pump superfamilies and their respective substrates.

  2022cites this paper
• A state-of-the-art review and prospective therapeutic applications of prenyl flavonoids as chemosensitizers against antifungal multidrug resistance in Candida albicans.

  2022cites this paper
• Directed Mutational Strategies Reveal Drug Binding and Transport by the MDR Transporters of Candida albicans

  2021cites this paper
• Inhibitor-Resistant Mutants Give Important Insights into Candida albicans ABC Transporter Cdr1 Substrate Specificity and Help Elucidate Efflux Pump Inhibition

  2021cites this paper
• Structural Insights into the Azole Resistance of the Candida albicans Darlington Strain Using Saccharomyces cerevisiae Lanosterol 14α-Demethylase as a Surrogate

  2021cites this paper
• Casearia sylvestris essential oil and its fractions inhibit Candida albicans ABC transporters related to multidrug resistance (MDR)

  2021cites this paper
• Terbinafine and Itraconazole Resistance in Dermatophytes

  2021cites this paper
• Turning Inside Out: Filamentous Fungal Secretion and Its Applications in Biotechnology, Agriculture, and the Clinic

  2021cites this paper
• Engineering a Cysteine-Deficient Functional Candida albicans Cdr1 Molecule Reveals a Conserved Region at the Cytosolic Apex of ABCG Transporters Important for Correct Folding and Trafficking of Cdr1

  2021cites this paper
• Fungal Lanosterol 14α-demethylase: A target for next-generation antifungal design.

  2020cites this paper
• ERG 11 gene polymorphisms and susceptibility to fluconazole in Candida isolates from diabetic and kidney transplant patients

  2019cites this paper
• Multidrug transporters of Candida species in clinical azole resistance.

  2019cites this paper
• Attenuated apoptotic BAX expression as a xenobiotic reporter in Saccharomyces cerevisiae.

  2019cites this paper
• Cdr1p highlights the role of the non-hydrolytic ATP-binding site in driving drug translocation in asymmetric ABC pumps.

  2019cites this paper
• New pathogens, new tricks: emerging, drug‐resistant fungal pathogens and future prospects for antifungal therapeutics

  2019cites this paper
• Anticandidal agent for multiple targets: the next paradigm in the discovery of proficient therapeutics/overcoming drug resistance.

  2019cites this paper
• Can Saccharomyces cerevisiae keep up as a model system in fungal azole susceptibility research?

  2019cites this paper
• ERG11 gene polymorphisms and susceptibility to fluconazole in Candida isolates from diabetic and kidney transplant patients.

  2019cites this paper
• Trichophyton rubrum Azole Resistance Mediated by a New ABC Transporter, TruMDR3

  2019cites this paper
• Insights on the anticandidal activity of non-antifungal drugs.

  2019cites this paper
• Azole Resistance Reduces Susceptibility to the Tetrazole Antifungal VT-1161

  2018influential citation
• All about CDR transporters: Past, present, and future

  2018cites this paper
• FK506 Resistance of Saccharomyces cerevisiae Pdr5 and Candida albicans Cdr1 Involves Mutations in the Transmembrane Domains and Extracellular Loops

  2018cites this paper
• Using Yeast to Discover Inhibitors of Multidrug Efflux in Candida albicans

  2017cites this paper
• Mechanisms of Drug Resistance in Candida albicans

  2017cites this paper
• Structure–Function Analyses of Multidrug Transporters

  2017cites this paper
• Emerging Mycotoxins: Beyond Traditionally Determined Food Contaminants.

  2017cites this paper
• Modulators of the Efflux Pump Cdr1p of Candida albicans: Mechanisms of Action and Chemical Features.

  2017cites this paper
• Antifungal adjuvants: Preserving and extending the antifungal arsenal

  2017cites this paper
• Resistance to antifungal therapies.

  2017cites this paper
• Targeting efflux pumps to overcome antifungal drug resistance.

  2016cites this paper
• Erratum: Newly identified motifs in Candida albicans Cdr1 protein nucleotide binding domains are pleiotropic drug resistance subfamily-specific and functionally asymmetric

  2016cites this paper
• A New Endogenous Overexpression System of Multidrug Transporters of Candida albicans Suitable for Structural and Functional Studies

  2016cites this paper
• Newly identified motifs in Candida albicans Cdr1 protein nucleotide binding domains are pleiotropic drug resistance subfamily-specific and functionally asymmetric

  2016cites this paper
• ABC transporter Cdr1p harbors charged residues in the intracellular loop and nucleotide-binding domain critical for protein trafficking and drug resistance.

  2015cites this paper
• Inhibitors of the Candida albicans Major Facilitator Superfamily Transporter Mdr1p Responsible for Fluconazole Resistance

  2015cites this paper
• The ABCs of Candida albicans Multidrug Transporter Cdr1

  2015cites this paper
• Multidrug resistance in pathogenic yeasts: emphasis on the role of ABC and MFS multidrug transporters

  2015cites this paper
• Mutational Analysis of Intracellular Loops Identify Cross Talk with Nucleotide Binding Domains of Yeast ABC Transporter Cdr1p

  2015cites this paper
• Comparative genomics of Mycobacterium tuberculosis drug efflux pumps and their transcriptional regulators.

  2014cites this paper
• Efflux pump proteins in antifungal resistance

  2014cites this paper
• Heterologous expression of membrane proteins in Saccharomyces cerevisiae

  2014cites this paper
• Biocidal and inhibitory activity screening of de novo synthesized surfactants against two eukaryotic and two prokaryotic microbial species.

  2013cites this paper
• Rationally Designed Transmembrane Peptide Mimics of the Multidrug Transporter Protein Cdr1 Act as Antagonists to Selectively Block Drug Efflux and Chemosensitize Azole-resistant Clinical Isolates of Candida albicans*♦

  2013cites this paper
• Overcoming the antifungal drug resistance of biofilms on dental acrylic

  2013cites this paper
• Small, synthetic, GC-rich mRNA stem-loop modules 5′ proximal to the AUG start-codon predictably tune gene expression in yeast

  2013cites this paper
• Insight into Pleiotropic Drug Resistance ATP-binding Cassette Pump Drug Transport through Mutagenesis of Cdr1p Transmembrane Domains*

  2013cites this paper